---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-031487"
form_type: "8-K"
ticker: "FEED"
cik: "0001326706"
company_name: "ENvue Medical, Inc."
filed_at: "2023-09-01T23:59:59+00:00"
generated_at: "2026-06-11T00:24:02.003236+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# NanoVibronix raises ~$5M in private placement of common stock and warrants

## Summary
- Offering of 2,906,977 shares (or equivalents) plus A-1 and A-2 warrants each for up to 2,906,977 shares at $1.72/unit.
- A-1 warrants exercisable at $1.47/share for 5.5 years; A-2 warrants identical with 13-month term.
- Gross proceeds ~$5M, net ~$4.3M after fees; closing expected Sept 1, 2023.
- Proceeds for general corporate purposes including development, sales/marketing, and potential acquisitions.

## SEC filing metadata
- accession: 0001493152-23-031487
- form_type: 8-K
- ticker: FEED
- cik: 0001326706
- company_name: ENvue Medical, Inc.
- filed_at: 2023-09-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326706/000149315223031487/0001493152-23-031487-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326706/000149315223031487/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-031487
- JSON: https://secwatch.observer/filing/0001493152-23-031487.json
- Plain text: https://secwatch.observer/filing/0001493152-23-031487.txt

## Key facts
- Material Agreements
  ENvue Medical, Inc. entered into Securities Purchase Agreement with institutional investor valued at 180,000 shares common stock, pre-funded warrants for 2,726,977 shares, A-1 Warrants for 2,906,977 sh (effective 2023-08-30).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: institutional investor
  - Value: 180,000 shares common stock, pre-funded warrants for 2,726,977 shares, A-1 Warrants for 2,906,977 sh
  - Effective: 2023-08-30
  source text: On August 30, 2023, NanoVibronix, Inc. (the “ Company ”) entered into a securities purchase agreement (the “ Purchase Agreement ”) with an institutional investor for the issuance and sale in a private placement (the “ Private Placement ”) of 180,000 shares (the “ Common Shares ”) of common stock, par value $0.001 per share (the “ Common Stock ”) , pre-funded warrants (“ Pre-Funded Warrants ”) to purchase up to 2,726,977 shares of common stock, with an exercise price of $0.0001 per share, A-1 Warrants (the “ A-1 Warrants ”) to purchase up to 2,906,977 shares of Common Stock, with an exercise price of $1.47 per share, and A-2 Warrants (the “ A-2 Warrants ” and together with the A-1 Warrants, the “ Warrants” ) to purchase up to 2,906,977 shares of Common Stock with an exercise price of $1.47 per share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326706/000149315223031487/0001493152-23-031487-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.